PTC Therapeutics, Inc. (PTCT) Presents at Bank of America Global Healthcare Conference 2026 Transcript
PTC Therapeutics Inc PTCT
$70.15
▼ -1.85%
($-1.32)
Open
$71.45
Prev Close
$71.47
Day Range
$69.81 – $72.13
52W Range
$43.18 – $87.50
Market Cap
$5.82B
P/E (TTM)
8.68
Beta
0.53
EPS (TTM)
$-2.32
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2013-06-20 |
| Shares Out. | 82,770,000 |
| Website | ptcbio.com/ ↗ |
| Phone | 13026365400 |
PTC Therapeutics Inc is a publicly traded company under the ticker symbol PTCT on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
22 analysts (2026-05-01)
📰 Latest News for PTCT
Transcript : PTC Therapeutics, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 08
PTC Therapeutics : Corporate Presentation – May 2026
PTC Therapeutics: Sephience Turns The Story From Regulatory Repair To Operating Leverage
PTC Therapeutics Q1 Earnings Call Highlights
Sector Update: Healthcare Stocks Lower Late Afternoon
TD Cowen Upgrades PTC Therapeutics to Buy, Raises Price Target to $90
RBC Capital Maintains Sector Perform on PTC Therapeutics, Raises Price Target to $82